For Patients and Families For Healthcare Professionals

Are you a healthcare professional?

I am

Go back

Knopp Biosciences
  • Pipeline
  • Dexpramipexole
    • Market Landscape
  • Kv7 Platform
    • KCNQ2-EE Mutation
  • Knopp Biosciences
  • News & Resources
  • For Patients and Families
social-link social-link social-link
Inquire

News and Resources

Dexpramipexole Kv 7 Company News
  • All
  • Presentations
  • Publications
08.04.18

American Society of Hematology: “Dexpramipexole: a new antieosinophil drug?”

Discover this News
01.01.18

American Society of Hematology: “Dexpramipexole as an oral steriod-sparing agent in hypereosinophilic syndromes”

Discover this News
01.01.18

The Laryngoscope: “Dexpramipexole Depletes Blood and Tissue Eosinophils in Nasal Polyps”

Discover this News
01.16.17

Elsevier: “The targeted eosinophil-lowering effects of dexpramipexole in clinical studies”

Discover this News
social-link social-link social-link

Learn More About the Unmet Needs We Strive to Address

Read Our Blog

Keep Up with Knopp, See What We Are Doing Next.




    Knopp Biosciences
    • Dexpramipexole
      • Market Landscape
    • Kv7 Platform
      • KCNQ2-EE Mutation
    • Pipeline
    • Knopp Biosciences
    • News & Resources
    Inquire +1 412-488-1776
    © Copyright 2021 Knopp Biosciences LLC. All Rights Reserved
    Privacy Policy Terms of Use
    social-link social-link social-link

    Knopp Disclaimer

    Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.

    This site uses cookies as explained in our Privacy Policy. If you agree to our use of cookies, please accept, alternatively, you can change your settings and decline.